Aspen Aerogels (NYSE:ASPN) Reaches New 1-Year High at $31.49

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) reached a new 52-week high on Monday . The company traded as high as $31.49 and last traded at $31.49, with a volume of 2657 shares. The stock had previously closed at $29.92.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ASPN. HC Wainwright boosted their price target on Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Roth Mkm reiterated a “buy” rating and issued a $22.00 target price on shares of Aspen Aerogels in a research note on Tuesday, April 30th. Canaccord Genuity Group upped their target price on Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. Finally, B. Riley upped their target price on Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. One analyst has rated the stock with a sell rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $26.33.

View Our Latest Stock Report on Aspen Aerogels

Aspen Aerogels Stock Performance

The stock has a 50-day simple moving average of $21.63 and a 200-day simple moving average of $16.73. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The stock has a market cap of $2.21 billion, a PE ratio of -65.92 and a beta of 2.28.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.14. Aspen Aerogels had a negative return on equity of 6.35% and a negative net margin of 10.73%. The firm had revenue of $94.50 million during the quarter, compared to the consensus estimate of $73.04 million. Equities analysts predict that Aspen Aerogels, Inc. will post 0.08 earnings per share for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the business’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $23.50, for a total transaction of $82,250,000.00. Following the completion of the sale, the insider now owns 12,280,426 shares of the company’s stock, valued at $288,590,011. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO Donald R. Young sold 256,944 shares of the company’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the sale, the chief executive officer now owns 502,855 shares of the company’s stock, valued at $14,703,480.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Wood River Capital, Llc sold 3,500,000 shares of the company’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $23.50, for a total value of $82,250,000.00. Following the completion of the sale, the insider now directly owns 12,280,426 shares of the company’s stock, valued at approximately $288,590,011. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 3,832,103 shares of company stock valued at $91,679,369. Company insiders own 4.30% of the company’s stock.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently modified their holdings of the stock. Virtu Financial LLC purchased a new position in Aspen Aerogels in the first quarter valued at about $246,000. Strategic Wealth Partners Ltd. boosted its holdings in Aspen Aerogels by 8.3% in the first quarter. Strategic Wealth Partners Ltd. now owns 68,980 shares of the construction company’s stock valued at $1,214,000 after purchasing an additional 5,305 shares during the last quarter. Comerica Bank purchased a new position in Aspen Aerogels in the first quarter valued at about $1,992,000. California State Teachers Retirement System boosted its holdings in Aspen Aerogels by 8.6% in the first quarter. California State Teachers Retirement System now owns 60,039 shares of the construction company’s stock valued at $1,057,000 after purchasing an additional 4,734 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC boosted its holdings in Aspen Aerogels by 48.0% in the first quarter. Silvercrest Asset Management Group LLC now owns 478,193 shares of the construction company’s stock valued at $8,416,000 after purchasing an additional 155,110 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.